QQ客服 官方微博 反馈留言

	Designing influenza polymerase acidic endonuclease inhibitors via 'privileged scaffold' re-evolution/refining strategy
	Ju, Han; Zhan, Peng; Liu, Xinyong
刊名	FUTURE MEDICINAL CHEMISTRY
	2019
卷号	11期号:4页码:265-268
关键词	baloxavir influenza virus polymerase acidic endonuclease 'privileged scaffold' re-evolution/refining
DOI	10.4155/fmc-2018-0489
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4540551
专题	山东大学
作者单位	Shandong Univ, Key Lab Chem Biol, Sch Pharmaceut Sci, Dept Med Chem,Minist Educ, 44 West Culture Rd, Jinan 250012,
推荐引用方式 GB/T 7714	Ju, Han,Zhan, Peng,Liu, Xinyong. Designing influenza polymerase acidic endonuclease inhibitors via 'privileged scaffold' re-evolution/refining strategy[J]. FUTURE MEDICINAL CHEMISTRY,2019,11(4):265-268.
APA	Ju, Han,Zhan, Peng,&Liu, Xinyong.(2019).Designing influenza polymerase acidic endonuclease inhibitors via 'privileged scaffold' re-evolution/refining strategy.FUTURE MEDICINAL CHEMISTRY,11(4),265-268.
MLA	Ju, Han,et al."Designing influenza polymerase acidic endonuclease inhibitors via 'privileged scaffold' re-evolution/refining strategy".FUTURE MEDICINAL CHEMISTRY 11.4(2019):265-268.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。